ArticleProceedings of the National Academy of Sciences of the United States of America2012

Retraction for Lammerts van Bueren et al. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Jeroen J Lammerts van Bueren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.